Antibodies as biological markers for pathophysiological processes in MS.
about
Antibody biomarkers in CNS demyelinating diseases - a long and winding roadThe spectrum of MOG autoantibody-associated demyelinating diseasesDiagnostic biomarkers in multiple sclerosis.Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.Categorization of multiple sclerosis relapse subtypes by B cell profiling in the bloodAntibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study.Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.Role of pathogens in multiple sclerosisConformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.Dysregulated Epstein-Barr virus infection in the multiple sclerosis brainMyocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapyAnalysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis.Cellular approaches for stimulating CNS remyelination.Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?The immunopathophysiology of multiple sclerosis.The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates.Detection of antibodies to the 20s proteasome by ELISA.
P2860
Q28262403-216E3318-F685-4C83-B7B8-C27C5413B45DQ28293355-A4B04DCC-2C13-4812-B1B4-AA7DBEDD30A1Q30598338-9B4B85A2-F57E-4FC6-AE0B-51E91808A923Q33599648-624BF3D7-6D4A-459A-9B4B-341BD76F7B0FQ34024209-8667AF95-ECEA-45DF-A627-D67110FFDDC8Q34253359-2F04B798-FE93-4DBD-97CE-EB9688032150Q34387874-FB5F0689-812B-4067-9F81-17D31DB4B2D9Q34835462-007B6168-EA26-4EA1-A07B-1787913DE62DQ35206805-69600C43-C4DC-4639-B043-1F674B06CD12Q35614751-FEC83ACC-E89F-466F-876F-E1211F34CB4BQ36229219-F08082F6-0F60-4C36-9A13-74ED32D649DBQ36647124-B34F79FF-748B-4486-8CB2-C91E7276FAB9Q36707237-87F46AE1-0E45-42C2-9084-5F6D0DB05CBCQ36956709-55236065-71CE-487A-90F4-09469337B502Q37582663-DD0AC094-09FC-4BE7-BC28-75D98E6F4D31Q37857982-93327AF5-5B86-4B53-A671-4BB249631F0DQ38001792-DB523839-1066-49B4-9F04-F0DA39EE97A8Q39352482-6F6016F7-D64A-44D4-BEA8-8F9356A3FCF3Q45363596-2D0962F5-99DB-4210-8DA1-98A16512C86E
P2860
Antibodies as biological markers for pathophysiological processes in MS.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antibodies as biological markers for pathophysiological processes in MS.
@ast
Antibodies as biological markers for pathophysiological processes in MS.
@en
type
label
Antibodies as biological markers for pathophysiological processes in MS.
@ast
Antibodies as biological markers for pathophysiological processes in MS.
@en
prefLabel
Antibodies as biological markers for pathophysiological processes in MS.
@ast
Antibodies as biological markers for pathophysiological processes in MS.
@en
P1476
Antibodies as biological markers for pathophysiological processes in MS.
@en
P2093
Thomas Berger
P356
10.1016/J.JNEUROIM.2006.06.028
P577
2006-08-23T00:00:00Z